About Catalase
Catalase (CAT) is a protein
from Homo sapiens identified by UniProt accession
P04040, 527 residues long.
MolForge cross-references it against 0 known binders and
1,074 disease associations.
Target properties
| Protein name | Catalase |
| UniProt accession | P04040 |
| Gene | CAT |
| Organism | Homo sapiens |
| Length | 527 residues |
| Molecular weight | — |
| EC numbers | — |
| Target class | UNCLASSIFIED |
| Subcellular location | — |
| Keywords | — |
Druggability
Target tractability assessment (Open Targets + pocket analysis). No approved drug
| Druggability tier | MEDIUM |
| Druggability score | — |
| Pocket score | — |
| Max clinical phase | — |
Disease associations (1074)
Diseases linked to this target (Open Targets).
- acatalasia · score 0.72
- blood protein measurement · score 0.32
- catalase measurement · score 0.29
- neurodegenerative disease · score 0.22
- cutaneous melanoma · score 0.18
- breast adenocarcinoma · score 0.18
- neoplasm · score 0.12
- hepatocellular carcinoma · score 0.10
- type 2 diabetes mellitus · score 0.10
- pancreatic adenocarcinoma · score 0.10
3D Structure (1)
Experimental (PDB) and predicted (AlphaFold) structures for this protein.
| Structure | Source | Method | Mean pLDDT | Resolution (Å) |
| AF-P04040-F1 | alphafold | PREDICTED | 95.79 | — |
Amino-acid sequence (527 residues)
MADSRDPASD QMQHWKEQRA AQKADVLTTG AGNPVGDKLN VITVGPRGPL LVQDVVFTDE MAHFDRERIP ERVVHAKGAG AFGYFEVTHD ITKYSKAKVF EHIGKKTPIA VRFSTVAGES GSADTVRDPR GFAVKFYTED GNWDLVGNNT PIFFIRDPIL FPSFIHSQKR NPQTHLKDPD MVWDFWSLRP ESLHQVSFLF SDRGIPDGHR HMNGYGSHTF KLVNANGEAV YCKFHYKTDQ GIKNLSVEDA ARLSQEDPDY GIRDLFNAIA TGKYPSWTFY IQVMTFNQAE TFPFNPFDLT KVWPHKDYPL IPVGKLVLNR NPVNYFAEVE QIAFDPSNMP PGIEASPDKM LQGRLFAYPD THRHRLGPNY LHIPVNCPYR ARVANYQRDG PMCMQDNQGG APNYYPNSFG APEQQPSALE HSIQYSGEVR RFNTANDDNV TQVRAFYVNV LNEEQRKRLC ENIAGHLKDA QIFIQKKAVK NFTEVHPDYG SHIQALLDKY NAEKPKNAIH TFVQSGSHLA AREKANL
Explore Catalase with MolForge
Find binders, run structure-based screening, and map this target across
diseases and approved drugs with our AI-powered platform.
Browse all targets